2-([(4-ETHYLPHENYL)AMINO]CARBONYL)BENZOIC ACID
![2-([(4-ETHYLPHENYL)AMINO]CARBONYL)BENZOIC ACID price.](/StructureFile/ChemBookStructure1/GIF/CB8208606.gif)
|
- $29.8 - $942
- Product name: 2-([(4-ETHYLPHENYL)AMINO]CARBONYL)BENZOIC ACID
- CAS: 17332-33-1
- MF: C16H15NO3
- MW: 269.3
- EINECS:
- MDL Number:MFCD00029954
- Synonyms:4'-ETHYLPHTHALANILIC ACID;IFLAB-BB F0777-0934;2-([(4-ETHYLPHENYL)AMINO]CARBONYL)BENZOIC ACID;AKOS BBS-00004737;2-((4-ethylphenyl)carbamoyl)benzoic acid;Benzoic acid, 2-[[(4-ethylphenyl)amino]carbonyl]-
4 prices
Selected condition：
Brand
- Crysdot
- Sigma-Aldrich
Package
- 50mg
- 1g
- 5g
- 10g
- ManufacturerCrysdot
- Product numberCD12133046
- Product description2-((4-Ethylphenyl)carbamoyl)benzoicacid 95+%
- Packaging1g
- Price$317
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12133046
- Product description2-((4-Ethylphenyl)carbamoyl)benzoicacid 95+%
- Packaging5g
- Price$624
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12133046
- Product description2-((4-Ethylphenyl)carbamoyl)benzoicacid 95+%
- Packaging10g
- Price$942
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS719552
- Product description4'-ETHYLPHTHALANILIC ACID Aldrich
- Packaging50mg
- Price$29.8
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD12133046 | 2-((4-Ethylphenyl)carbamoyl)benzoicacid 95+% | 1g | $317 | 2021-12-16 | Buy |
| Crysdot | CD12133046 | 2-((4-Ethylphenyl)carbamoyl)benzoicacid 95+% | 5g | $624 | 2021-12-16 | Buy |
| Crysdot | CD12133046 | 2-((4-Ethylphenyl)carbamoyl)benzoicacid 95+% | 10g | $942 | 2021-12-16 | Buy |
| Sigma-Aldrich | S719552 | 4'-ETHYLPHTHALANILIC ACID Aldrich | 50mg | $29.8 | 2024-03-01 | Buy |
Properties
Safety Information
| Symbol(GHS): |
 
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|